AFP and hepatocellular carcinoma: Several recent studies have demonstrated that formate is a useful biomarker in HCC [32–34]; however, what we have shown is that formate itself is a highly specific and selective biomarker for the prediction of VI and a combination of formate, tumor size and AFP further improves its performance.